These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 3401631)
1. Hypoglycaemic and hypoketonaemic effects of single and repeated oral doses of methyl palmoxirate (methyl 2-tetradecylglycidate) in streptozotocin/alloxan-induced diabetic dogs. Tuman RW; Tutwiler GF; Joseph JM; Wallace NH Br J Pharmacol; 1988 May; 94(1):130-6. PubMed ID: 3401631 [TBL] [Abstract][Full Text] [Related]
2. Effect of the fatty acid oxidation inhibitor methyl palmoxirate (methyl 2-tetradecylglycidate) on recovery from insulin-induced hypoglycemia in diabetic dogs. Tuman RW; Bowden CR; Inman M; Altszuler N; Tutwiler GF J Pharmacol Exp Ther; 1989 Sep; 250(3):836-41. PubMed ID: 2674419 [TBL] [Abstract][Full Text] [Related]
3. Pharmacologic profile of methyl 2-tetradecylglycidate (McN-3716)--an orally effective hypoglycemic agent. Tutwiler GF; Kirsch T; Mohrbacher RJ; Ho W Metabolism; 1978 Oct; 27(10):1539-56. PubMed ID: 692381 [TBL] [Abstract][Full Text] [Related]
4. Effects of the oral hypoglycemic agent methyl palmoxirate on exercise capacity of rats. Young JC; Bryan JE; Constable SH; Tutwiler GF; Holloszy JO Can J Physiol Pharmacol; 1984 Jul; 62(7):815-8. PubMed ID: 6498613 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of mitochondrial carnitine palmitoyl transferase A in vivo with methyl 2-tetradecylglycidate (methyl palmoxirate) and its relationship to ketonemia and glycemia. Tutwiler GF; Brentzel HJ; Kiorpes TC Proc Soc Exp Biol Med; 1985 Feb; 178(2):288-96. PubMed ID: 3969383 [TBL] [Abstract][Full Text] [Related]
6. Effects of oral hypoglycemic agent methylpalmoxirate on exercise capacity of streptozocin diabetic rats. Young JC; Treadway JL; Fader EI; Caslin RF Diabetes; 1986 Jul; 35(7):744-8. PubMed ID: 3721061 [TBL] [Abstract][Full Text] [Related]
7. Methyl palmoxirate increases Ca2+-myosin ATPase activity and changes myosin isoenzyme distribution in the diabetic rat heart. Dillmann WH Am J Physiol; 1985 May; 248(5 Pt 1):E602-6. PubMed ID: 3158215 [TBL] [Abstract][Full Text] [Related]
8. Phenylalkyloxirane carboxylic acids, a new class of hypoglycaemic substances: hypoglycaemic and hypoketonaemic effects of sodium 2-[5-(4-chlorophenyl)-pentyl]-oxirane-2-carboxylate (B 807-27) in fasted animals. Wolf HP; Eistetter K; Ludwig G Diabetologia; 1982 Jun; 22(6):456-63. PubMed ID: 6213437 [TBL] [Abstract][Full Text] [Related]
9. Prevention of diabetes-induced myocardial dysfunction in rats by methyl palmoxirate and triiodothyronine treatment. Tahiliani AG; McNeill JH Can J Physiol Pharmacol; 1985 Aug; 63(8):925-31. PubMed ID: 2934121 [TBL] [Abstract][Full Text] [Related]
10. Effect of methyl palmoxirate, an oral hypoglycemic agent, on epinephrine-induced hyperglycemia in the rat. Tutwiler GF; Joseph J; Wallace N Biochem Pharmacol; 1985 Jun; 34(12):2217-20. PubMed ID: 4004943 [No Abstract] [Full Text] [Related]
11. Effects of subbasal insulin infusion on resting and exercise-induced glucose turnover in depancreatized dogs. Shi ZQ; Giacca A; Yamatani K; Fisher SJ; Lickley HL; Vranic M Am J Physiol; 1993 Mar; 264(3 Pt 1):E334-41. PubMed ID: 8460681 [TBL] [Abstract][Full Text] [Related]
12. Methyl 2-tetradecylglycidate, an orally effective hypoglycemic agent that inhibits long chain fatty acid oxidation selectively. Tutwiler GF; Mohrbacher R; Ho W Diabetes; 1979 Mar; 28(3):242-8. PubMed ID: 446909 [No Abstract] [Full Text] [Related]
13. Impact of in vivo fatty acid oxidation blockade on glucose turnover and muscle glucose metabolism during low-dose AICAR infusion. Christopher M; Rantzau C; Chen ZP; Snow R; Kemp B; Alford FP Am J Physiol Endocrinol Metab; 2006 Nov; 291(5):E1131-40. PubMed ID: 16772328 [TBL] [Abstract][Full Text] [Related]
14. Effects of blockade of fatty acid oxidation on whole body and tissue-specific glucose metabolism in rats. Jenkins AB; Storlien LH; Cooney GJ; Denyer GS; Caterson ID; Kraegen EW Am J Physiol; 1993 Oct; 265(4 Pt 1):E592-600. PubMed ID: 8238335 [TBL] [Abstract][Full Text] [Related]
16. Effects of intravenous methyl palmoxirate on the turnover and oxidation of fatty acids in conscious dogs. Bailey JW; Jensen MD; Miles JM Metabolism; 1991 Apr; 40(4):428-31. PubMed ID: 1901373 [TBL] [Abstract][Full Text] [Related]
17. Effect of the fatty acid oxidation inhibitor 2-tetradecylglycidic acid on pyruvate dehydrogenase complex activity in starved and alloxan-diabetic rats. Caterson ID; Fuller SJ; Randle PJ Biochem J; 1982 Oct; 208(1):53-60. PubMed ID: 7159398 [TBL] [Abstract][Full Text] [Related]
18. Hypoglycaemic effects of myrtle oil in normal and alloxan-diabetic rabbits. Sepici A; Gürbüz I; Cevik C; Yesilada E J Ethnopharmacol; 2004 Aug; 93(2-3):311-8. PubMed ID: 15234770 [TBL] [Abstract][Full Text] [Related]
19. Insulin secretagogue effect of Ichnocarpus frutescence leaf extract in experimental diabetes: a dose-dependent study. Subash-Babu P; Ignacimuthu S; Agastian P Chem Biol Interact; 2008 Mar; 172(2):159-71. PubMed ID: 18258225 [TBL] [Abstract][Full Text] [Related]
20. FK-614, a selective peroxisome proliferator-activated receptor gamma agonist, improves peripheral glucose utilization while decreasing hepatic insulin extraction in alloxan-induced diabetic dogs. Uchino H; Kim T; Lam TK; Yoshii H; Klement P; Williams W; Kawamori R; Giacca A Metabolism; 2005 Sep; 54(9):1250-8. PubMed ID: 16125538 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]